PALO ALTO, Calif. and NASHVILLE, Tenn. – Syapse, the leading provider of software for bringing omics data into routine medical use, announced today at the American College of Medical Genetics (ACMG) Annual Meeting that it will enable popular third-party commercial omics interpretation providers to make their content available to Syapse customers through the Syapse platform. Syapse also announced that its customers will be able to integrate public and open databases, such as ClinVar, COSMIC, PhenoDB, and OMIM, through standard connectors in its platform.

Syapse customers will be able to select sources of interpretive content that reflect their expertise and judgment. The Syapse platform will seamlessly integrate content from supported providers with knowledge from internal experts and public databases to create a customized, unified knowledge base for each customer. This integration will enable hospitals and laboratories to automate the assembly of actionable omics-based recommendations for use in reporting of molecular diagnostics tests and clinical decision support.

“The ability to access biomedical knowledge from best-in-class providers is critical for TOMA’s products to be clinically relevant,” said Mike Lucero, CEO of TOMA Biosciences. “Accurate interpretation of complex genomic data requires more than one source of knowledge. The Syapse solution integrates disparate sources to produce clinically meaningful recommendations in an easy-to-use and highly scalable manner.”

Supported third-party interpretation providers will be announced in subsequent press releases in the coming weeks. Third-party providers interested in connecting to the Syapse platform should contact bizdev@syapse.com.

Integration of interpretive content will be a standard part of the Syapse for Labs and Syapse for Hospitals products. For more information and pricing, visit www.syapse.com.

About Syapse

Syapse is disrupting healthcare by bringing omics into routine medical use. Syapse provides a precision medicine data platform to enable laboratories, registries, and hospitals to use molecular profiling to diagnose and treat patients. Led by an experienced, multidisciplinary team of entrepreneurs, software developers, and scientists, Syapse was founded at Stanford University and is backed by The Social+Capital Partnership. For more information, please visit www.syapse.com.